Omega Healthcare Investors Inc. (OHI) Given a $35.00 Price Target by Jefferies Group Analysts
Omega Healthcare Investors Inc. (NYSE:OHI) received a $35.00 price objective from Jefferies Group in a research note issued on Friday. The firm presently has a a “buy” rating on the real estate investment trust’s stock. Jefferies Group’s price target points to a potential upside of 19.49% from the company’s previous close.
Other analysts have also issued research reports about the company. Thomas Weisel reissued a “buy” rating and set a $35.85 price target on shares of Omega Healthcare Investors in a report on Monday, August 1st. JMP Securities lowered Omega Healthcare Investors from an “outperform” rating to a “market perform” rating in a report on Thursday, August 18th. They noted that the move was a valuation call. Vetr raised Omega Healthcare Investors from a “hold” rating to a “buy” rating and set a $35.84 price target for the company in a report on Wednesday, July 27th. SunTrust Banks Inc. boosted their price target on Omega Healthcare Investors from $38.00 to $42.00 and gave the company a “buy” rating in a report on Thursday, August 4th. Finally, Zacks Investment Research upgraded Omega Healthcare Investors from a “hold” rating to a “buy” rating and set a $40.00 price objective on the stock in a research report on Tuesday, August 9th. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $36.59.
Shares of Omega Healthcare Investors (NYSE:OHI) opened at 29.29 on Friday. Omega Healthcare Investors has a 12-month low of $26.96 and a 12-month high of $38.09. The firm has a 50 day moving average price of $32.65 and a 200 day moving average price of $33.87. The stock has a market cap of $5.72 billion, a PE ratio of 18.63 and a beta of 0.59.
Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Monday, October 31st. The real estate investment trust reported $0.80 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.84 by $0.04. Omega Healthcare Investors had a net margin of 34.53% and a return on equity of 7.37%. The company had revenue of $224.60 million for the quarter, compared to the consensus estimate of $186.35 million. During the same period in the prior year, the firm posted $0.79 EPS. The business’s revenue for the quarter was up 11.8% on a year-over-year basis. On average, equities analysts expect that Omega Healthcare Investors will post $3.39 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 15th. Investors of record on Monday, October 31st will be given a $0.61 dividend. This is an increase from Omega Healthcare Investors’s previous quarterly dividend of $0.60. This represents a $2.44 dividend on an annualized basis and a dividend yield of 8.33%. The ex-dividend date is Thursday, October 27th. Omega Healthcare Investors’s payout ratio is currently 155.42%.
In other news, Director Bernard J. Korman bought 100,000 shares of the firm’s stock in a transaction that occurred on Friday, November 4th. The shares were bought at an average cost of $29.29 per share, for a total transaction of $2,929,000.00. Following the completion of the transaction, the director now owns 774,685 shares of the company’s stock, valued at $22,690,523.65. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO C Taylor Pickett bought 21,800 shares of the firm’s stock in a transaction that occurred on Friday, November 4th. The stock was purchased at an average price of $29.26 per share, for a total transaction of $637,868.00. Following the completion of the transaction, the chief executive officer now directly owns 276,261 shares of the company’s stock, valued at approximately $8,083,396.86. The disclosure for this purchase can be found here. 4.54% of the stock is owned by corporate insiders.
Large investors have recently modified their holdings of the stock. Moors & Cabot Inc. increased its stake in shares of Omega Healthcare Investors by 9.2% in the third quarter. Moors & Cabot Inc. now owns 7,951 shares of the real estate investment trust’s stock worth $282,000 after buying an additional 667 shares during the period. The Manufacturers Life Insurance Company bought a new stake in shares of Omega Healthcare Investors during the third quarter worth about $9,656,000. Affinity Wealth Management bought a new stake in shares of Omega Healthcare Investors during the third quarter worth about $235,000. Two Sigma Advisers LP increased its stake in shares of Omega Healthcare Investors by 5.4% in the third quarter. Two Sigma Advisers LP now owns 390,704 shares of the real estate investment trust’s stock worth $13,850,000 after buying an additional 19,900 shares during the period. Finally, Teachers Insurance & Annuity Association of America increased its stake in shares of Omega Healthcare Investors by 2.2% in the third quarter. Teachers Insurance & Annuity Association of America now owns 182,355 shares of the real estate investment trust’s stock worth $6,464,000 after buying an additional 3,880 shares during the period. Institutional investors and hedge funds own 84.20% of the company’s stock.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc (Omega) is a self-administered real estate investment trust (REIT). The Company invests in income producing healthcare facilities, long-term care facilities located throughout the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
Receive News & Stock Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related stocks with our FREE daily email newsletter.